140 related articles for article (PubMed ID: 8297546)
1. Pharmacokinetics of fluvastatin and specific drug interactions.
Smith HT; Jokubaitis LA; Troendle AJ; Hwang DS; Robinson WT
Am J Hypertens; 1993 Nov; 6(11 Pt 2):375S-382S. PubMed ID: 8297546
[TBL] [Abstract][Full Text] [Related]
2. Development and pharmacology of fluvastatin.
Jokubaitis LA
Br J Clin Pract Suppl; 1996 Jan; 77A():11-5. PubMed ID: 8729584
[TBL] [Abstract][Full Text] [Related]
3. Development and pharmacology of fluvastatin.
Jokubaitis LA
Br J Clin Pract Suppl; 1994 Dec; (77):11-5. PubMed ID: 19489169
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of the biopharmaceutical properties of fluvastatin.
Deslypere JP
Am J Cardiol; 1994 May; 73(14):12D-17D. PubMed ID: 8198018
[TBL] [Abstract][Full Text] [Related]
5. Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacy.
Dujovne CA; Davidson MH
Am J Med; 1994 Jun; 96(6A):37S-40S. PubMed ID: 8017465
[TBL] [Abstract][Full Text] [Related]
6. Effects of alcohol consumption on pharmacokinetics, efficacy, and safety of fluvastatin.
Smit JW; Wijnne HJ; Schobben F; Sitsen A; de Bruin TW; Erkelens DW
Am J Cardiol; 1995 Jul; 76(2):89A-96A. PubMed ID: 7604808
[TBL] [Abstract][Full Text] [Related]
7. Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.
Bard JM; Ose L; Hagen E; Duriez P; Pfister P; Fruchart JC; Dallongeville J
Am J Cardiol; 1995 Jul; 76(2):65A-70A. PubMed ID: 7604802
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
[TBL] [Abstract][Full Text] [Related]
9. Steady-state pharmacokinetics of fluvastatin in healthy subjects following a new extended release fluvastatin tablet, Lescol XL.
Barilla D; Prasad P; Hubert M; Gumbhir-Shah K
Biopharm Drug Dispos; 2004 Mar; 25(2):51-9. PubMed ID: 14872552
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein composition.
Bard JM; Dallongeville J; Hagen E; Pfister P; Ose L; Fruchart JC; Duriez P
Metabolism; 1995 Nov; 44(11):1447-54. PubMed ID: 7476333
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of fluvastatin.
Scripture CD; Pieper JA
Clin Pharmacokinet; 2001; 40(4):263-81. PubMed ID: 11368292
[TBL] [Abstract][Full Text] [Related]
12. Effects of alcohol and fluvastatin on lipid metabolism and hepatic function.
Smit JW; Wijnne HJ; Schobben F; Sitsen A; De Bruin TW; Erkelens DW
Ann Intern Med; 1995 May; 122(9):678-80. PubMed ID: 7702230
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
14. Disposition of fluvastatin, an inhibitor of HMG-COA reductase, in mouse, rat, dog, and monkey.
Tse FL; Smith HT; Ballard FH; Nicoletti J
Biopharm Drug Dispos; 1990; 11(6):519-31. PubMed ID: 2207302
[TBL] [Abstract][Full Text] [Related]
15. High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits.
Kurokawa J; Hayashi K; Toyota Y; Shingu T; Shiomi M; Kajiyama G
Biochim Biophys Acta; 1995 Oct; 1259(1):99-104. PubMed ID: 7492622
[TBL] [Abstract][Full Text] [Related]
16. Safety, tolerability, and pharmacokinetics of an extended-release formulation of fluvastatin administered once daily to patients with primary hypercholesterolemia.
Sabia H; Prasad P; Smith HT; Stoltz RR; Rothenberg P
J Cardiovasc Pharmacol; 2001 May; 37(5):502-11. PubMed ID: 11336101
[TBL] [Abstract][Full Text] [Related]
17. Fluvastatin in combination with other lipid-lowering agents.
Jokubaitis LA
Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270
[TBL] [Abstract][Full Text] [Related]
18. Fluvastatin in combination with other lipid-lowering agents.
Jokubaitis LA
Br J Clin Pract Suppl; 1996 Jan; 77A():28-32. PubMed ID: 8729588
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers.
Tse FL; Jaffe JM; Troendle A
J Clin Pharmacol; 1992 Jul; 32(7):630-8. PubMed ID: 1640002
[TBL] [Abstract][Full Text] [Related]
20. Fluvastatin in familial hypercholesterolemia: a cohort analysis of the response to combination treatment.
Muratti EN; Peters TK; Leitersdorf E
Am J Cardiol; 1994 May; 73(14):30D-38D. PubMed ID: 8198022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]